In October 2020, India and South Africa proposed a landmark intellectual property waiver at the World Trade Organisation to temporarily waive patents related to COVID-19 diagnostics, drugs and vaccines for as long as the pandemic rages on. While this has been backed by more than a 100 governments, progress has been blocked - unsurprisingly - by a handful of wealthy countries. Now with many countries across the globe with high vaccination rates and beginning to treat COVID-19 as endemic, you might ask why such a waiver is still needed. Here to answer that question and the problems exposed by a recently leaked draft of the proposal is Chee Yoke Ling, the executive director of the Third World Network.

Image credit: Shutterstock

Produced by: Lim Sue Ann

Presented by: Lim Sue Ann

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  health policy

Tags:  World Trade Organization,  TRIPS Waiver,  evergreening,  the bigger picture,  live and learn,  covid-19,  sars-cov-2,  wto,  intellectual property,  patents,  vaccines,  antivirals,  copyright,